TheStreet, Inc. (TST) Declares $0.025 Quarterly Dividend; 5.7% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St futures decline as oil surge, high yields stoke inflation worries
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Goldman Sachs sees 18% upside for Palantir on sovereign AI growth
- Citi names 5 top chip picks ahead of Q3 earnings
- PepsiCo shares climb after Q3 beat, though company trims profit forecast
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
- Wall Street ends lower, off record highs, as Treasury yields climb
- Applied Digital (APLD) Tops Q1 EPS by 26c, Beats on Revenue
TheStreet, Inc. Announces Quarterly Dividend
August 31, 2015 4:01 PM EDTNEW YORK, Aug. 31, 2015 /PRNewswire/ -- TheStreet, Inc. (NASDAQ: TST), a leading digital financial media company, announced today that its board of directors has declared a quarterly cash dividend on the Company's common stock. The cash dividend of $0.025 per share of common stock will be payable on September 30, 2015 to all shareholders of... More
Telesta Receives FDA BLA Filing Notification Letter and Priority Review Designation for MCNA(1)
August 28, 2015 1:23 PM EDTMONTREAL, Aug. 28 2015 /PRNewswire/ - Telesta Therapeutics Inc. (TSX: TST) (PNK: BNHLF) announced today that it has received its BLA Filing Notification for MCNA from the U.S. Food and Drug Administration (FDA). This formal letter communicates that the FDA has completed its initial review of Telesta's Biologics License Application (BLA) submitted on June 29, 2015 and has accepted it for filing. In the same letter, the FDA communicated that it has designated the file for 6 month Priority Review and has set February 27,... More



